Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PARACOR-19: Entresto for Post-COVID Cardiac Protection
NCT04883528Phase 2Completed
- Sponsor
- Duke University
- Start
- Aug 2021
- Primary completion
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sacubitril + valsartan in coronavirus disease 2019 (COVID-19), sponsored by Duke University. Started Aug 2021; status: completed.
02
Drugs
sacubitril + valsartan
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04883528.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04883528.